Endometriosis Market 2020 Top Leading Companies, Key Segments, Growth Analysis, Business Overview and Regional Outlook 2026 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Endometriosis Market 2020 Top Leading Companies, Key Segments, Growth Analysis, Business Overview and Regional Outlook 2026

Description:

The global endometriosis market size was worth USD 1.90 billion in 2017 and is expected to grow on account of an increasing number of patients across the globe, specifically in regions such as North America and Europe. In 2015, 1.8 billion women within the age group 15 to 49 years received treatment, globally. – PowerPoint PPT presentation

Number of Views:15
Date added: 5 August 2020
Slides: 6
Provided by: Thomashinds
Category:

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Endometriosis Market 2020 Top Leading Companies, Key Segments, Growth Analysis, Business Overview and Regional Outlook 2026


1
Global Endometriosis Market
  • Size by Drug Type (NSAIDs, Gonadotropins
    Releasing Hormone Agonists, Progestin, and Oral
    Contraceptive Pills) by Region and Forecast 2018
    to 2025

Single Use License US 4400
Request Sample
2
Global Endometriosis Market Size, Share , Price
Analysis Report 2025
  • Adroit Market Research launched a study titled,
    Global Endometriosis Market Size by Drug Type
    (NSAIDs, Gonadotropins Releasing Hormone
    Agonists, Progestin, and Oral Contraceptive
    Pills), by Region and Forecast 2018 to 2025. The
    study covers the global endometriosis drugs
    market value for a period ranging in between 2015
    to 2025, where 2015 to 2017 imply the historical
    value with forecast between 2018 and 2025. The
    global endometriosis treatment market report also
    includes qualitative insights of the market such
    as pipeline analysis, porters five forces
    analysis, drivers and restraints. Trends for the
    global endometriosis diagnosis market have also
    been covered in this study.
  • The global endometriosis market size is expected
    to reach USD 2.29 billion by 2025. The increasing
    female population within the age group of 15-49
    years across developed as well as developing
    economies is expected to fuel the endometriosis
    drugs market growth over the forecast period.
    High prevalence of endometriosis among the female
    population of reproductive age is expected to
    drive the endometriosis treatment market demand
    in the coming years.
  • Symptoms such as pain instantly before and during
    a period, ovulation pain, and irregular or heavy
    bleeding during periods have resulted in a
    significant decrease in working female
    population. Productivity loss of approximately 11
    hours per week has been observed in diagnosed
    patients. High prevalence, undefined etiology,
    and high productivity loss are major factors
    resulting in a large number of research
    institutes and drug manufacturers engaging in
    research for optimum diagnosis and treatment for
    the condition.
  • Drug classes namely NSAIDs, gonadotropins
    releasing hormone agonists, oral contraceptives,
    and progestin therapy are widely used for pain
    management post-diagnosis. Nonsteroidal
    anti-inflammatory drug segment dominated the
    global endometriosis market by contributing major
    market share and is expected to maintain its
    dominance over the forecast period contributing
    to40.6 of the revenues by 2025.

3
Global Endometriosis Market Size, Share , Price
Analysis Report 2025
  • Presence of a large number of companies actively
    involved in clinical trials for disease
    management is expected to change the current
    market dynamics in the coming years. In April
    2018, Bayer in collaboration with Evotec
    announced phase I trials of new small molecules
    for the treatment of endometriosis. Furthermore,
    as of January 2019, 24 studies are under phase
    III and are expected to show positive results,
    which will provide opportunities for the further
    development of the global endometriosis treatment
    market.
  • North America dominated the global endometriosis
    market in 2017 and is expected to grow at a
    lucrative CAGR by 2025. High prevalence within
    the U.S., coupled with the presence of a large
    number of working female population has created a
    potential market for drug manufacturers.
    According to ENDOFOUND.ORG, 7 million women in
    the U.S. have endometriosis. On the other hand,
    the financial burden of USD 87 billion has been
    estimated within the U.S. every year for medical
    costs and reduced work productivity. Such factors
    are expected to support regional growth over the
    forecast period.
  • The global endometriosis market is marked by the
    presence of well-established drug manufacturers
    such as AstraZeneca, Bayer AG, Neurocrine
    Biosciences, Inc., Meditrina Pharmaceuticals Inc.
    and many more. Major players within the market
    are actively involved in clinical trials to
    develop novel treatment and diagnosis options to
    reduce the financial burden of the medical
    condition.
  • Browse the complete report on _at_
    https//www.adroitmarketresearch.com/industry-repo
    rts/endometriosis-market

4
Key segments of the global endometriosis market
  • Drug Type Overview, 2015-2025 (USD million)
  • NSAIDs
  • Gonadotropins Releasing Hormone agonists
  • Progestin
  • Oral contraceptive pills
  • Regional Overview, 2015-2025 (USD million)
  • North America
  • Europe
  • Asia Pacific
  • Rest of the World
  • Purchase a single user copy of the global
    endometriosis market report_at_ https//www.adroitmar
    ketresearch.com/researchreport/purchase/784

5
About Us
  • Adroit Market Research is an India-based business
    analytics and consulting company. Our target
    audience is a wide range of corporations,
    manufacturing companies, product/technology
    development institutions and industry
    associations that require understanding of a
    markets size, key trends, participants and
    future outlook of an industry. We intend to
    become our clients knowledge partner and provide
    them with valuable market insights to help create
    opportunities that increase their revenues. We
    follow a code Explore, Learn and Transform. At
    our core, we are curious people who love to
    identify and understand industry patterns, create
    an insightful study around our findings and churn
    out money-making roadmaps. Our analysts have
    tracked high growth markets in chemicals
    materials, healthcare pharmaceuticals,
    semiconductor electronics, energy power, food
    retail, consumer goods, technology, and
    machinery equipment sectors across the world to
    identify new opportunities, potential customers,
    prepare go-to-market (GTM) strategies, identify
    segments for revenue growth for companies, and
    many more.
  • US Headquarters3131 McKinney Ave Ste 600
    Dallas, TX 75204 ,U.S.A 
  • Phone 1 (214) 884-6068
  • Email sales_at_adroitmarketresearch.com
About PowerShow.com